4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Whitehawk Therapeutics, Inc. (WHWK) operates in the Biotechnology industry and is headquartered in Morristown, United States with about 29 employees. Its market capitalization is roughly $191 million. In the fiscal year ended 2025-12-31, WHWK reported $7M in revenue and ($21M) in net income.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $7M | $26M | $24M | $15M | — |
| Gross Profit | $6M | $23M | $22M | $14M | — |
| Operating Income (EBIT) | ($114M) | ($65M) | ($72M) | ($59M) | — |
| Net Income | ($21M) | ($64M) | ($66M) | ($60M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $7M | — |
| Gross Profit | $0M | $0M | $0M | $0M | $6M | — |
| Operating Income (EBIT) | ($24M) | ($25M) | ($20M) | ($55M) | ($15M) | — |
| Net Income | ($22M) | ($23M) | ($18M) | ($53M) | $73M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | $0M | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $151M | $70M | $132M | $184M | — |
| Total Liabilities | $14M | $18M | $27M | $26M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WHWK viewer.
About TickerBase · Data methodology & sources